Prof. dr. Matthijs Verhage obtained his PhD at the University of Amsterdam in 1990 (cum laude). He received post-doctoral training at the labs of prof. David G. Nicholls (Dundee, UK) and the recent Nobel laureate prof. Thomas C. Südhof (Howard Hughes Medical Institute, Dallas, USA).
Since 2000 he is full professor and head of the Department of Functional Genomics at the VU University Medical Center and a department of the same name at the Faculty of Life Sciences, Vrije Universiteit, Amsterdam, The Netherlands
In 2003 he became the first chairman of the Center for Neurogenomics and Cognitive Research (CNCR). He was co-founder and vice chair of the Dutch NeuroBsik Mouse Phenomics consortium.
Since 2014, he is also affiliated with the Karolinska Institutet in Stockholm, Sweden (SUN project, 0.1fte).
Since 2015, he is also affiliated with the Broad Institute at the Massachusetts Institute of Technology (MIT) in Boston, USA (SYNGO project, 0.1fte).
Matthijs Verhage was co-founder and vice chair of the Dutch NeuroBsik Mouse Phenomics consortium, partner of the European research consortium EU-Synapse, vice chair of the consortia EuroSpin and SynSys and is founder and vice chair of the recently awarded H2020 consortium COSYN.
He is chair/member of the scientific advisory/review boards of the Center for Psychiatry and Neuroscience (Descartes), in Paris, France; the graduate school Neurosciences in Göttingen, Germany; the European Neuroscience Institute in Göttingen, Germany; the IBS Center for Synaptic Brain Dysfunctions, Deajeon, Korea; the Flanders Institute for Biotechnology (VIB), Leuven, Belgium; the CNC-IBILI in Coimbra, Portugal and the Centro de Biología Molecular Severo Ochoa, Madrid, Spain.
He is consultant/scientific advisor for Life Science companies in The Netherlands, Spain, Switzerland and Japan.
In 2001 he was the Pionier/VICI laureate of the Dutch Organization for Scientific Research (NWO).
In 2012 he received the ERC Ideas Advanced Grant of the European Research Council.
Some key papers of the last 10 years:
- Persoon et al. (2018) EMBO J. e99672
- Emperador-Melero et al. (2018) Nature Commun 9(1): 3421.
- Kovacevic et al. (2018) Brain 141(5): 1350-1374.
- Meijer et al. (2018) EMBO J. 37(2): 300-320.
- Emperador Melero et al. (2017) Stem Cell Reports 8(3): 659-672.
- He et al. (2017) Nature Commun 8: 15915.
- de Jong et al. (2016) Proc Natl Acad Sci U S A 113(18): 5095-5100.
- Aarts et al. (2016) Nature Neurosci 17(4): 491-496.
- Li et al. (2013) Neuron 79(5): 970-986.
- Ripke et al. (2013) Nature Genet 45(10): 1150-1159.
- Heutink and Verhage (2012) Neuron 75(6): 935-938.
- Toonen and M. Verhage (2011) Neuron 72(5): 679-681.
- Groffen et al. (2010) Science 327(5973): 1614-1618
- Mohrmann et al. (2010) Science 330(6003): 502-505.
- de Wit et al. (2009) Cell 138(5): 935-946.
- Verhage and van Meer (2009) Neuron 62(5): 603-605.
- Gerber et al. (2008) Science 321(5895): 1507-1510.
- Wierda et al (2008) Neuron 54(2): 275-290.
|Address:||A-435, W&N building|
|Telephone:||+31 (0) 20 59 86925|